Nutra Pharma Corp Stock Fundamentals
| NPHC Stock | USD 0.0001 0.00 0.00% |
Nutra Pharma Corp fundamentals help investors to digest information that contributes to Nutra Pharma's financial success or failures. It also enables traders to predict the movement of Nutra Pink Sheet. The fundamental analysis module provides a way to measure Nutra Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutra Pharma pink sheet.
Nutra |
Nutra Pharma Corp Company Return On Asset Analysis
Nutra Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Nutra Pharma Return On Asset | -1.13 |
Most of Nutra Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutra Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Nutra Pharma Corp has a Return On Asset of -1.1323. This is 87.06% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Nutra Pharma Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutra Pharma's current stock value. Our valuation model uses many indicators to compare Nutra Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutra Pharma competition to find correlations between indicators driving Nutra Pharma's intrinsic value. More Info.Nutra Pharma Corp is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nutra Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nutra Pharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nutra Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nutra Pharma's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nutra Pharma could also be used in its relative valuation, which is a method of valuing Nutra Pharma by comparing valuation metrics of similar companies.Nutra Pharma is currently under evaluation in return on asset category among its peers.
Nutra Fundamentals
| Return On Asset | -1.13 | |||
| Profit Margin | 28.71 % | |||
| Operating Margin | (5.58) % | |||
| Current Valuation | 10.33 M | |||
| Shares Outstanding | 7.6 B | |||
| Shares Owned By Insiders | 1.02 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Sales | 6.13 X | |||
| Revenue | 51.9 K | |||
| Gross Profit | 8.47 K | |||
| EBITDA | (365.66 K) | |||
| Net Income | (769.18 K) | |||
| Cash And Equivalents | 10.45 K | |||
| Total Debt | 517.18 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (878.09 K) | |||
| Target Price | 0.53 | |||
| Beta | 0.25 | |||
| Market Capitalization | 759.68 K | |||
| Total Asset | 301.79 K | |||
| Z Score | -2.7 | |||
| Net Asset | 301.79 K |
About Nutra Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nutra Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nutra Pink Sheet
Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.